Although guidelines do not recommend computerised tomography (CT), positron emission tomography (PET) or magnetic resonance imaging (MRI) for the staging or follow-up of asymptomatic patients with non-metastatic breast cancer, they are often requested in routine clinical practice. The aim of this study was to determine the staging and follow-up patterns, and relative costs in a large population of breast cancer patients living and treated in a Southern Italian region.
Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications / DE PLACIDO, Sabino; DE ANGELIS, Carmine; Giuliano, Mario; Pizzi, C; Ruocco, R; Perrone, V; Bruzzese, Dario; Tommasielli, G; DE LAURENTIIS, Michelino; Cammarota, S; Arpino, Grazia; Arpino, G.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 116:6(2017), pp. 821-827-827. [10.1038/bjc.2017.24]
Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications
DE PLACIDO, SABINO;DE ANGELIS, CARMINESecondo
;GIULIANO, MARIO;BRUZZESE, DARIO;DE LAURENTIIS, MICHELINO;ARPINO, GRAZIA
;
2017
Abstract
Although guidelines do not recommend computerised tomography (CT), positron emission tomography (PET) or magnetic resonance imaging (MRI) for the staging or follow-up of asymptomatic patients with non-metastatic breast cancer, they are often requested in routine clinical practice. The aim of this study was to determine the staging and follow-up patterns, and relative costs in a large population of breast cancer patients living and treated in a Southern Italian region.| File | Dimensione | Formato | |
|---|---|---|---|
|
bjc201724a.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
678.84 kB
Formato
Adobe PDF
|
678.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
